Diagnostic value of the serum galactomannan assay for invasive aspergillosis: It is less useful in non-haematological patients

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 8, 2012, Pages 600-604

  Ku, Nam Su ^a   Han, Sang Hoon ^a   Choi, Jun Yong ^a   Kim, Sun Bean ^a   Kim, Hye Won ^a   Jeong, Su Jin ^a   Kim, Chang Oh ^a   Song, Young Goo ^a   Kim, June Myung ^a  

^a Yonsei University   (South Korea)

Author keywords

Galactomannan assay; Invasive aspergillosis; Non haematological patients

Indexed keywords

GALACTOMANNAN;

ADULT; AGED; ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; GALACTOMANNAN ASSAY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPERGILLOSIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MANNANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84864033007     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.657672     Document Type: Article

References (29)

1. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34: 909-17.
2. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005;18:44-69.
3. Bretagne S, Marmorat-Khuong A, Kuentz M, Latge JP, Bart-Delabesse E, Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997;35:7-15.
4. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001;97:1604-10.
5. Bretagne S, Costa JM, Bart-Delabesse E, Dhedin N, Rieux C, Cordonnier C. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998;26:1407-12.
6. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999;37:3223-8.
7. Ulusakarya A, Chachaty E, Vantelon JM, Youssef A, Tancrede C, Pico JL, et al. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. Hematol J 2000; 1:111-6.
8. Bouza E, Guinea J, Pelaez T, Perez-Molina J, Alcala L, Munoz P. Workload due to Aspergillus fumigatus and signifi cance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol 2005;43:2075-9.
9. Ader F, Nseir S, Le Berre R, Leroy S, Tillie-Leblond I, Marquette CH, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005;11:427-9.
10. Vandewoude KH, Blot SI, Benoit D, Colardyn F, Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect 2004;56:269-76.
11. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
12. Guinea J, Jensen J, Pelaez T, Gijon P, Alonso R, Rivera M, et al. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol 2008;46:575-9.
13. Singh N. Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management. Med Mycol 2005;43(Suppl 1):S267-70.
14. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003;17:113-34, viii.
15. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006;42:1417-27.
16. Fortun J, Martin-Davila P, Alvarez ME, Sanchez-Sousa A, Quereda C, Navas E, et al. Aspergillus antigenemia sandwich- enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 2001;71:145-9.
17. Husain S, Kwak EJ, Obman A, Wagener MM, Kusne S, Stout JE, et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004; 4:796-802.
18. Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne S, et al. Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004;42:435-8.
19. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001;91:311-8.
20. Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002;21:240-8.
21. Bennett JE, Friedman MM, Dupont B. Receptor-mediated clearance of Aspergillus galactomannan. J Infect Dis 1987; 155:1005-10.
22. Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint- Martin C, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15:232-7.
23. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995;33:497-500.
24. Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006;44:389-94.
25. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specifi city of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997;35:257-60.
26. Kami M, Kanda Y, Ogawa S, Mori S, Tanaka Y, Honda H, et al. Frequent false-positive results of Aspergillus latex agglutination test: transient Aspergillus antigenemia during neutropenia. Cancer 1999;86:274-81.
27. Sulahian A, Tabouret M, Ribaud P, Sarfati J, Gluckman E, Latge JP, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996;15:139-45.
28. Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer s disease: a population-based cohort study. Diabetologia 2009; 52:1031-9.
29. Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006;44:335-42.